期刊文献+

尿脱落细胞吖啶橙染色检查在膀胱癌诊断中的应用价值 被引量:1

Acridine orange fluorescene in diagnosis of bladder cancer
原文传递
导出
摘要 目的探讨尿脱落细胞吖啶橙荧光染色(AO-F)检查在膀胱癌诊断中的应用价值。方法回顾性分析1016例膀胱癌患者资料,按临床分期、病理分级、肿瘤大小、数目、部位、手术治疗方式及有无血尿症状,分别计算AO-F阳性率,并进行统计学分析。结果1016例患者尿样AO-F阳性率78.05%(793/1016),表浅癌和浸润癌患者阳性率分别为74.69%(611/818)和91.92%(182/198);病理分级≤Ⅱ级和Ⅲ级患者阳性率分别为67.24%(351/522)和90.37%(413/457);有无血尿症状患者阳性率分别为80.30%(750/934)和52.44%(43/82);肿瘤直径≥2cm和〈2cm患者阳性率分别为79.87%(710/889)和65.35%(83/127);多发和单发肿瘤患者阳性率分别为83.07%(363/437)和74.27%(430/579);肿瘤累及膀胱三角区或膀胱颈部者阳性率为77.21%(105/136),累及其他部位者为78.07%(687/880);治疗方法TURBt、膀胱部分切除和膀胱全切除患者阳性率分别为69.68%(393/564),87.87%(268/305)和91.74%(100/109)。AO-F阳性率与膀胱癌临床分期、病理分级、手术治疗方式、肿瘤大小、数目及有无血尿症状等因素有明显相关性,且与其临床分期、病理分级间存在正相关(r值分别为0.99和0.97);患者性别及肿瘤发生部位等因素与AO-F阳性率之间无相关性。结论尿脱落细胞AO-F检查诊断膀胱癌阳性率高,且简便、无创、经济、准确性高,可反复进行,可提高膀胱癌患者的早期诊断率,值得临床推广应用。 Objective To investigate the diagnostic value of acridine orange fluorescene(AO-F) in bladder cancers. Methods One thousand and sixteen bladder cancer patients were reviewed retro spectively. The positive-rates of AO-F in different stages, grades, size, quantity, position of tumors, hematuria and treatment ways were evaluated. Results The total positive rate of AO-F was 78.05 % (793/1016). The positive-rate was 74.69% (611/818) in superficial stage and 91.92% (182/198) in invasive bladder cancer, 67.24% (351/522) in grade Ⅰ and Ⅱ , 90.37% (413/457) in grade Ⅲ. The percentage of positive AO-F was 80.30% (750/934) in patients with hematuria, 52.44% (43/82) in patients without hematuria. The percentage was 79.87% (710/889) when the tumor size was more than 2 cm, 65.35% (83/127) when size less than 2 cm. 83.07% (363/437) sample was positive in muhiple tumors, 74. 27% (430/579) in single tumor. The percentage was 77. 21% (105/136) in tumors involving trigone or neck of bladder, 78.07% (687/880) in tumors without involving these regions. There was 69.68% (393/564) in treatment with TURBt, 87.87% (268/305) in partial resection, 91.74% (100/109) in total resection. A good association was observed between stage, grade, hematuria appearance, tumor size, quantity of carcinoma, treatment way and AO-F positive-rate, and a linear correlation was present between grade, stage and positive cytology. There was no significant association between position of the tumor and AO-F positive-rate. Conclusions The function of AO-F is significant in diagnosis of bladder cancer.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2009年第4期245-247,共3页 Chinese Journal of Urology
关键词 膀胱肿瘤 尿 细胞诊断学 Bladder neoplasms Urine Cytodiagnosis
  • 相关文献

参考文献4

二级参考文献14

  • 1王国民 缪廷杰 张元芳 熊汝成 周康 许迅辉.尿脱落细胞吖啶橙染色法诊断膀胱癌[J].临床泌尿外科杂志,1987,2(2):76-78.
  • 2Park YN, Chae KJ, Kim YB. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis. Cancer,2001,92:2733-2738.
  • 3Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis.Genes Dev, 1999,13:239-252.
  • 4Ambrosini G,Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med, 1997,3:917-921.
  • 5Swana H S, Grossman D, Anthony JN ,et al. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med, 1999,341:452-453.
  • 6Smith SD, Wheeler MA, Plescia J, et al. Urine detection of survivin and diagnosis of badder cancer. JAMA ,2001,285:324-328.
  • 7Freeman A, Morris LS, Mills AD, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res, 1999,5:2121-2132.
  • 8Williams GH, Romanowski P, Morris L, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci USA, 1998,95 : 14932-14937.
  • 9Stoeber K, Swinn R, Prevost AT, et al. Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst,2002 ,94 :1071-1079.
  • 10Sanchez-Carbayo M, Herrero E, Megias J, et al. Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen,tissue polypeptide antigen and NMP22 to detect bladder cancer. J Urol, 1999,162 : 1951.

共引文献9

同被引文献9

  • 1吴阶平.尿脱落细胞学检查//吴阶平.吴阶平泌尿外科学.济南:山东科学技术出版社,2004:419-420.
  • 2May M,Hakenberg OW,Gunia S,et al.Comparative diagnostic value of urine cytology,UBC-ELISA,and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in ruitine clinical practice.Urology,2007,70:449-453.
  • 3Planz B,Jochims E,Deix T,et al.The role of urinary cytology for detection of bladder cancer.Eur J Surg Oncol,2005,31:304-308.
  • 4Boman H,Hedelin H,Holmang S.Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade reourence.J Urol,2002,167:80-83.
  • 5Talwar R,Sinha T,Karan SC,et al.Voided urinary cytology in bladder cancer:is it time to review the indications?Urology,2007,70:267-271.
  • 6Raitanen M,Aine R,Rintala E,et al.Differences between local and review urinary cytology and diagnosis of bladder cancer.Eur Urol,2002,41:284-289.
  • 7Placer J,Espinet B,Salido M,et al.Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences,compared with urinary cytology.Eur Urol,2002,42:547-552.
  • 8Malik SN,Murphy WM.Monitoring patients for bladder neoplasms:what can be expected of urinary cytology consultations in clinical practice.Urology,1999,54:62-66.
  • 9Zein TA,Milad MF.Urine cytology in bladder tumor.Int Surg,1991,76:52-54.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部